H
Haiying Zhu
Researcher at University of Washington
Publications - 15
Citations - 1215
Haiying Zhu is an academic researcher from University of Washington. The author has contributed to research in topics: Medicine & Immunology. The author has an hindex of 5, co-authored 7 publications receiving 779 citations.
Papers
More filters
Journal ArticleDOI
Diminished Humoral and Cellular Responses to SARS-CoV-2 Vaccines in Patients with Chronic Lymphocytic Leukemia
Chaitra S. Ujjani,Ted Gooley,Stephen E. Spurgeon,Deborah M. Stephens,Catherine Lai,Catherine M. Broome,Susan O'Brien,Haiying Zhu,Kerry J. Laing,Allison M. Winter,Georgios Pongas,Alexander L. Greninger,David M. Koelle,Tanya Siddiqi,Matthew S. Davids,Kerry A. Rogers,Alexey V. Danilov,Amy Sperling,Brian Tu,Tyler Sorensen,Kelsey Launchbury,C. Burrow,Genesis Quezada,Joshua A. Hill,Mazyar Shadman,P. D. Thompson +25 more
TL;DR: In this paper , a national collaboration of 11 cancer centers around the United States aimed to further characterize and understand the vaccine-induced immune response, including T-cell responses and the impact of CLL therapeutics (NCT04852822).
Journal ArticleDOI
2094. A prospective multicenter study of HHV-6B genomic DNA and gene transcription in paired bronchoalveolar lavage fluid and blood from HCT recipients
Joshua A. Hill,Yeon Joo Lee,Lisa K. Vande Vusse,Hu Xie,E. Lisa Chung,Jacob Keane-Candib,Alpana Waghmare,Guang-Shing Cheng,Haiying Zhu,Meei Li Huang,Geoffrey R. Hill,Keith R. Jerome,Sina A. Gharib,Wendy M. Leisenring,Danielle M. Zerr,Sanjeet Dadwal,Michael Boeckh +16 more
TL;DR: Hill et al. as discussed by the authors found that HHV-6B DNA was detected more frequently in bronchoalveolar lavage fluid (BALF) than plasma, suggesting compartment-specific reactivation.
Journal ArticleDOI
The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up
Chaitra S. Ujjani,Christina Poh,Brian Tu,Sydney Lee,Stacy Selke,Haiying Zhu,Mazyar Shadman,Ryan C. Lynch,Meei Li Huang,Ajay K. Gopal,Edus H. Warren,Brian G. Till,Stephen D. Smith,Amy Sperling,Joshua A. Hill,Philip A. Stevenson,Leslie Nielsen,Ted Gooley,Alexander L. Greninger +18 more
TL;DR: Ujjani et al. as mentioned in this paper presented the 1-year follow-up data of from their cohort and demonstrated the negative impact of Bruton tyrosine kinase (BTK) and B-cell lymphoma 2 (BCL-2) inhibitors on COVID vaccine efficacy for those with CLL with an overall seroconversion rate of 41%.
Journal ArticleDOI
The clinical and virological features of two children's coinfections with human adenovirus type 7 and human coronavirus-229E virus
Shelan Liu,A-gen Zhu,Jinren Pan,Lihong Ying,Hanting Wu,Haiying Zhu,Hai-Yan Lou,Lan Wang,Shuwen Qin,Zhao Yu,Jian Cai,Ying Chen,Enfu Chen +12 more
TL;DR: In this paper , the authors compared clinical manifestations, laboratory examinations, and disease severity between three groups: one coinfected with HAdV-Ad7 and HCoV-229E, one infected only with adenovirus (mono-adenovirus), and one infected infected with human coronavirus-229 E (Mono-HCoV229E) is very rare.
Journal ArticleDOI
A case report of primary cardiac angiosarcoma with DNMT3A gene mutation
TL;DR: To the knowledge, this is the first reported case of primary cardiac angiosarcoma with DNMT3A gene mutation, and it is proposed that surgery is the mainstay treatment strategy for patients with this condition.